TARS · Tarsus Pharmaceuticals, Inc.
$69.20
+0.32 (+0.46%)
At close · Aug 14
Market Cap
$3.04B
Shares
43.88M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-14 | 5,316 | $59.31 | $315,292 |
| 2026-07-01 | 122,000 | $62.94 | $7,678,680 |
| 2026-06-30 | 43,653 | $61.26 | $2,674,183 |
| 2026-06-29 | 132,239 | $62.92 | $8,320,478 |
| 2026-06-24 | 37,119 | $66.17 | $2,456,164 |
| 2026-06-08 | 9,788 | $59.28 | $580,233 |
| 2026-06-04 | 661 | $58.76 | $38,840 |
| 2026-06-03 | 3,725 | $57.41 | $213,852 |
| 2026-06-01 | 9,574 | $59.40 | $568,696 |
| 2026-05-29 | 50 | $59.54 | $2,977 |
| 2026-05-26 | 246 | $62.26 | $15,316 |
| 2026-05-19 | 2,000 | $62.82 | $125,640 |
| 2026-05-18 | 19 | $62.48 | $1,187 |
Showing 1–13 of 13 settlements
Key facts
CIK
1819790
CUSIP
87650L103
13F (30d)
246 filings
243 filers
Visit website
Investor relations